Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2005
05/26/2005US20050112630 detecting tumors via microarray analysisof transfection pattern of cancer marker gene; antitumor agents; anticancer agents
05/26/2005US20050112629 Detection reagent for thermostable direct hemolysin gene of Vibrio parahaemolyticus
05/26/2005US20050112628 Amplification using oligonucleotide primers
05/26/2005US20050112627 Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics
05/26/2005US20050112625 Denaturizing; separation; hybridization ; elongation
05/26/2005US20050112624 Method for typing of HLA class I alleles
05/26/2005US20050112623 Bio-cell chip
05/26/2005US20050112620 Nucleic acid labeled binding proteins
05/26/2005US20050112619 Length determination of nucleic acid repeat sequences by discontinuous primer extension
05/26/2005US20050112617 Method and device for the quantitative electrical detection of analytes
05/26/2005US20050112614 Generating set of tiles with binding segments; labeling
05/26/2005US20050112613 Sensitivty of infant to shortness ; analyzing Dna in genomes
05/26/2005US20050112612 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
05/26/2005US20050112611 Using nucleic acid
05/26/2005US20050112610 Detection using primers; topical applying to carrier
05/26/2005US20050112609 Probe composition and method
05/26/2005US20050112608 Probe composition and method
05/26/2005US20050112607 Analyzing for neurodegenerative disease; using immobilized colloidal particles
05/26/2005US20050112605 Biosensor that utilizes redox system to detect biopolymers
05/26/2005US20050112604 Diagnosis, monitoring cancer
05/26/2005US20050112602 cDNA chip for screening specific genes and analyzing their function in swine
05/26/2005US20050112601 Methods for cellular or microorganism capture and quantification using bioluminescence regenerative cycle (BRC) assays
05/26/2005US20050112600 Screening of expression profile of muscle specific genes expressed by growing stages in swine and functional cDNA chip prepared by using the same
05/26/2005US20050112599 Calibration of meat quality; immobilization probe containing fat specific genes
05/26/2005US20050112598 Using mitochondrial allelic variations; biochips; genetic screening; amplification, screening, diagnosis
05/26/2005US20050112597 Animal husbandry; screening genes using Dna chip
05/26/2005US20050112595 Analyzig nucleotide sequences; detection restriction fragment length polymorphism; forensics; heredity testing
05/26/2005US20050112594 Detecting target nucleic acid sequences; obtaining sample; incubation; monitoring migration of nucleotide sequence
05/26/2005US20050112592 Assay for species sources
05/26/2005US20050112591 Novel method for isolating single stranded product
05/26/2005US20050112590 Spectrometric analysis ; splitting compound; measurement signals; calibration
05/26/2005US20050112589 Microarray hybridization device
05/26/2005US20050112588 Methods and apparatus for analyzing arrays
05/26/2005US20050112587 Analyzing biological probes
05/26/2005US20050112586 Method and composition for stabilizing liquid reagents
05/26/2005US20050112585 Reagent immobilized on supports; contacting fluids ; binding
05/26/2005US20050112584 Using oligonucleotide probe; immobilization on substrate; measurement gene expression
05/26/2005US20050112583 Hybridization enclosure with oligonucleotide bonded to interior surraces; sample walls for holding nucleic acids; valve plates; amplification
05/26/2005US20050112581 Anticancer, antitumor agents; monitoring mutant oncogens; signal amplification
05/26/2005US20050112580 Bacillus stearothermophilus tau, delta, and delta prime polymerase subunits and use thereof
05/26/2005US20050112577 External data base; computer program
05/26/2005US20050112575 Nucleic acid sequence encoding polypeptides; triggering calcium oscillation in ooctyes ; determination fertility
05/26/2005US20050112574 Isolated nucleic acid; angiogenesis inhibitor
05/26/2005US20050112573 Method of detecting toxic substance
05/26/2005US20050112572 Detecting oxidation stresses in sampling using markers; measurement; calibration
05/26/2005US20050112570 Indicator for development of diabetes
05/26/2005US20050112569 Blood-relationship of a suspected-grandmother and a suspected-granddaughter can be confirmed in the absence of the father's DNA by comparing STR alleles on the X chromosome of each subject; STR DNA through PCR performed with STR on X chromosome
05/26/2005US20050112568 Dgks as modifiers of the p53 pathwha and methods of use
05/26/2005US20050112567 Serological assay for Neospora caninum
05/26/2005US20050112566 Free of solvents, chemicals, grinders, freezing, or detergents to remove the macromolecules from DNA, RNA, saccharide, protein, lipid biological materials; outer covering interruption; steady-state radio frequency
05/26/2005US20050112565 Proteases
05/26/2005US20050112563 Sub-sequences of 2'-deoxy-erythro-pentofuranosyl nucleotides that activate RNase H enzyme; diagnostics; antisense therapeutics
05/26/2005US20050112562 Inhibition of retroviral replication through modulation of the host cell ubiquitylation
05/26/2005US20050112561 Compositions and kits for herpes simplex virus type 1 and 2 nucleic acid detection
05/26/2005US20050112560 Serum biomarkers of hepatitis B virus infected liver and methods for detection thereof
05/26/2005US20050112559 Compositions and methods for diagnosing and preventing severe acute respiratory syndrome (SARS)
05/26/2005US20050112558 SARS-specific probes to the SARS-specific nucleic acid; quantitative assessment of the SARS-CoV viral titer found in a biological specimen from a patient
05/26/2005US20050112556 Drug screening; endogenous human retrovirus; protein or peptide expressed by said retrovirus
05/26/2005US20050112555 Cytidine deaminase activators, deoxycytidine deaminase activators, Vif antagonists, and methods of screening for molecules thereof
05/26/2005US20050112554 An insertion/a deletion early-stage-specific molecular marker, a single nucleotide variation (SNV) early-stage-specific molecular marker; SARS-CoV (coronaviruses) strains obtained from the earliest infected patients in a SARS outbreak, uses of these data for diagnosis, drug/vaccine development
05/26/2005US20050112551 screening for compounds that modulate cell receptor activity; target cells can be constructed that constitutively express a reporter gene responsive to cell viability; improved Renilla reniformis luciferase (rluc) genes
05/26/2005US20050112549 Method and apparatus for measuring nitric oxide production and oxygen consumption in cultures of adherent cells
05/26/2005US20050112547 Vaginal infection test system and method
05/26/2005US20050112546 Neural colony forming assay
05/26/2005US20050112544 analysis apparatus comprising electrode layouts on nonconducting substrates, impedance analyzers and software programs, used for analyzing cells; screening compounds that effect immunoglobulin mediated responses of cells to antigens
05/26/2005US20050112541 Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm
05/26/2005US20050112143 Method of developing an immunogenic composition and HIV vaccine
05/26/2005US20050112142 Methods and compositions for treatment and prevention of HSV-2 infections and conditions
05/26/2005US20050112140 Immunogenic composition and method of developing a vaccine based on portions of the HIV matrix protein
05/26/2005US20050112139 Immunogenic composition and method of developing a vaccine based on factor H binding sites
05/26/2005US20050112134 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease
05/26/2005US20050112129 Compositions and methods for the diagnosis and treatment of tumors of glial origin
05/26/2005US20050112128 Inhibition of protein kinase c-mu (PKD) as a treatment for cardiac hypertrophy and heart failure
05/26/2005US20050112118 Compositions and methods for treating inflammatory disorders
05/26/2005US20050112101 Methods of treating restenosis
05/26/2005US20050112064 DNA-dependent MRI contrast agents
05/26/2005US20050109637 Method and apparatus for assay of electrochemical properties
05/26/2005US20050109618 Meter for use in an improved method of reducing interferences in an electrochemical sensor using two different applied potentials
05/26/2005CA2793127A1 Oligonucleotides and methods for detection of west nile virus
05/26/2005CA2556643A1 Method to predict upper aerodigestive tract cancer
05/26/2005CA2552686A1 Isolation of nucleic acid from mouth epithelial cells
05/26/2005CA2546243A1 The mycolactone locus : an assembly line for producing novel polyketides, with therapeutic and prophylatic uses
05/26/2005CA2546171A1 Method of detecting mutations associated with thrombosis
05/26/2005CA2545807A1 Oligonucleotides and methods for detection of west nile virus
05/26/2005CA2545619A1 Short cycle methods for sequencing polynucleotides
05/26/2005CA2545482A1 Substrates, devices, and methods for cellular assays
05/26/2005CA2545475A1 Device for analyte measurement
05/26/2005CA2545423A1 Combinations for the treatment of proliferative diseases
05/26/2005CA2545356A1 Nucleic acid detection method having increased sensitivity
05/26/2005CA2545260A1 Compositions and methods for modulating c-rel-dependent cytokine production
05/26/2005CA2545252A1 Improved methods for detecting and measuring specific nucleic acid sequences
05/26/2005CA2545182A1 Improved methods and compositions for rna interference
05/26/2005CA2545066A1 A reagent system and method for modifying the luminescence of lanthanide(iii) macrocyclic complexes
05/26/2005CA2544976A1 Method of preparing nucleic acids for detection
05/26/2005CA2544836A1 High-density amine-functionalized surface
05/26/2005CA2544688A1 Cellular membrane protein assay
05/26/2005CA2544564A1 Methods, compositions, and automated systems for separating rare cells from fluid samples
05/26/2005CA2544506A1 Use of strain of lactobacillus and byproducts thereof for inhibiting formation of blood vessels
05/26/2005CA2544483A1 Soluble tcr fusion molecules and methods of use
05/26/2005CA2544369A1 Risk assessment for adverse drug reactions